How I treat chronic graft-versus-host disease - PubMed (original) (raw)
Review
. 2001 Mar 1;97(5):1196-201.
doi: 10.1182/blood.v97.5.1196.
Affiliations
- PMID: 11222360
- DOI: 10.1182/blood.v97.5.1196
Free article
Review
How I treat chronic graft-versus-host disease
G B Vogelsang. Blood. 2001.
Free article
Abstract
Allogeneic stem cell transplantation (SCT) is now a commonplace procedure. Clinicians who care for patients with hematologic malignancies and aplastic anemia are almost certain to follow up patients after SCT. This review is intended to help clinicians observe patients for probably the most important late complication of SCT, chronic graft-versus-host disease (GVHD). It reviews the pathophysiology, risk factors, clinical manifestations, evaluation, treatment, and supportive care of chronic GVHD.
Comment in
- An update on how to treat chronic GVHD.
Flowers ME, Lee S, Vogelsang G. Flowers ME, et al. Blood. 2003 Sep 15;102(6):2312. doi: 10.1182/blood-2003-06-2064. Blood. 2003. PMID: 12959944 No abstract available.
Similar articles
- Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
Funke VA, Moreira MC, Vigorito AC. Funke VA, et al. Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:44-50. doi: 10.1590/1806-9282.62.suppl1.44. Rev Assoc Med Bras (1992). 2016. PMID: 27982319 Review. - Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.
Kavand S, Lehman JS, Hashmi S, Gibson LE, El-Azhary RA. Kavand S, et al. Int J Dermatol. 2017 Feb;56(2):131-140. doi: 10.1111/ijd.13381. Epub 2016 Sep 23. Int J Dermatol. 2017. PMID: 27658806 Review. - The Pathophysiology and Treatment of Graft-_Versus_-Host Disease: Lessons Learnt From Animal Models.
Teshima T, Hill GR. Teshima T, et al. Front Immunol. 2021 Aug 19;12:715424. doi: 10.3389/fimmu.2021.715424. eCollection 2021. Front Immunol. 2021. PMID: 34489966 Free PMC article. Review. - Vulvovaginal Graft-Versus-Host Disease.
Kornik RI, Rustagi AS. Kornik RI, et al. Obstet Gynecol Clin North Am. 2017 Sep;44(3):475-492. doi: 10.1016/j.ogc.2017.05.007. Obstet Gynecol Clin North Am. 2017. PMID: 28778644 Review. - Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW. Park SS, et al. Biol Blood Marrow Transplant. 2017 Sep;23(9):1498-1508. doi: 10.1016/j.bbmt.2017.05.026. Epub 2017 May 26. Biol Blood Marrow Transplant. 2017. PMID: 28554856
Cited by
- Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial.
Nelson AM, Yang D, Jagielo AD, D'Alotto J, Poliquin C, Rabideau DJ, Cronin KG, Newcomb RA, Chen YB, DeFilipp Z, Greer JA, El-Jawahri A, Traeger L. Nelson AM, et al. J Natl Compr Canc Netw. 2024 Feb;22(1):34-42. doi: 10.6004/jnccn.2023.7080. J Natl Compr Canc Netw. 2024. PMID: 38394783 Clinical Trial. - Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
Buder K, Zirngibl M, Bapistella S, Meerpohl JJ, Strahm B, Bassler D, Weitz M. Buder K, et al. Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD009898. doi: 10.1002/14651858.CD009898.pub4. Cochrane Database Syst Rev. 2022. PMID: 35679154 Free PMC article. Review. - Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.
Kok LMC, Bungener L, de Bock GH, Biswana A, van der Wal G, van Imhoff GW, Bellido M. Kok LMC, et al. Hum Cell. 2020 Jan;33(1):243-251. doi: 10.1007/s13577-019-00297-7. Epub 2019 Nov 15. Hum Cell. 2020. PMID: 31732859 Free PMC article. - Ruxolitinib for Therapy of Graft-versus-Host Disease.
Neumann T, Schneidewind L, Weigel M, Plis A, Vaizian R, Schmidt CA, Krüger W. Neumann T, et al. Biomed Res Int. 2019 Mar 6;2019:8163780. doi: 10.1155/2019/8163780. eCollection 2019. Biomed Res Int. 2019. PMID: 30956985 Free PMC article. - [Efficacy of recombinant human coagulation factor Ⅶ and immunosuppressive agent in patients with acute intestinal graft versus host disease complicated with bleeding after allogeneic hematopoietic stem cell transplantation].
Chen X, Zhai WH, Ma QL, Yao JF, Li G, Liang C, Jiang EL, Feng SZ, Han MZ. Chen X, et al. Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):156-158. doi: 10.3760/cma.j.issn.0253-2727.2018.02.016. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562453 Free PMC article. Chinese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources